Journal of Clinical Oncology, Vol 5, 1673-1689, Copyright © 1987 by American Society of Clinical Oncology

ARTICLES

Lymphoproliferative diseases in immunocompromised hosts: the role of Epstein-Barr virus

AF List, FA Greco and LB Vogler
Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37237.

Epstein-Barr virus (EBV) is a ubiquitous transforming virus of the herpes group showing tropism for B lymphocytes. Primary infection in normal hosts results in a transient lymphoproliferative disorder, acute infectious mononucleosis (IM), that is restricted by cytotoxic and suppressive lymphocytes. However, in the immunodeficient host, EBV- induced lymphoproliferation may behave in a biologically malignant fashion. Patients with primary immunodeficiencies and those with immune incompetence resulting from suppressive therapy in allograft transplantation or infection with human immunodeficiency virus (HIV) have EBV-related illness ranging from fulminant mononucleosis and invasive polyclonal B cell hyperplasia to monoclonal B cell malignancies. While the direct link between EBV and malignant B cell proliferation in these patients has not been elucidated, the association has been increasingly recognized with improved techniques of viral detection. Clinical management can be guided by the location and extent of tumor, histologic features, and clonality. Regional and node-based polyclonal proliferations may respond to prompt reduction of immunosuppressive therapy and efforts to interrupt the replicative cycle with antiviral agents. Systemic cytotoxic therapy often leads to further immunosuppression and should be reserved for patients with progressive disease, advanced visceral involvement, and monoclonal lymphoid malignancies.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M S Dhillon, J K Rai, B K Gunson, S Olliff, and J Olliff Post-transplant lymphoproliferative disease in liver transplantation Br. J. Radiol., May 1, 2007; 80(953): 337 - 346. [Abstract] [Full Text] [PDF]

				V. S. Hershberger, R. K. Hutchins, D. P. Witte, S. Schneider, R. E. Harris, and S. J. McGonegle Epstein-Barr Virus-Related Bilateral Acute Retinal Necrosis in a Patient With X-linked Lymphoproliferative Disorder Arch Ophthalmol, July 1, 2003; 121(7): 1047 - 1049. [Full Text] [PDF]

				A S Shaw, S M Ryan, R C Beese, S Norris, M Bowles, M Rela, and P S Sidhu Liver transplantation Imaging, August 1, 2002; 14(4): 314 - 328. [Abstract] [Full Text] [PDF]

				P. J. Pickhardt, M. J. Siegel, R. J. Hayashi, and M. Kelly Posttransplantation Lymphoproliferative Disorder in Children: Clinical, Histopathologic, and Imaging Features Radiology, October 1, 2000; 217(1): 16 - 25. [Abstract] [Full Text]

				G. Guz, A. Arican, H. Karakayali, B. Demirhan, N. Bilgin, and M. Haberal Two renal transplants from one cadaveric donor: one recipient with simultaneous B cell lymphoma and Kaposi's sarcoma, and the other with T cell lymphoma Nephrol. Dial. Transplant., August 1, 2000; 15(8): 1242 - 1244. [Full Text] [PDF]

				A. C. Aisenberg Problems in Hodgkin's Disease Management Blood, February 1, 1999; 93(3): 761 - 779. [Full Text] [PDF]

				A. B. Satterthwaite, D. J. Rawlings, and O. N. Witte DSHP: A "power bar" for sustained immune responses? PNAS, November 10, 1998; 95(23): 13355 - 13357. [Full Text] [PDF]

				H. J. Deeg and G. Socie Malignancies After Hematopoietic Stem Cell Transplantation: Many Questions, Some Answers Blood, March 15, 1998; 91(6): 1833 - 1844. [Full Text] [PDF]

				R. M. Stone, E. J. Mark, and J. A. Ferry Case 31-1997- A 67-Year-Old Renal-Transplant-Recipient with Anemia, Leukopenia, and Pulmonary Lesions N. Engl. J. Med., October 9, 1997; 337(15): 1065 - 1074. [Full Text] [PDF]

				K. Tsukasaki, H. Tsushima, M. Yamamura, T. Hata, K. Murata, T. Maeda, S. Atogami, H. Sohda, S. Momita, S. Ideda, et al. Integration Patterns of HTLV-I Provirus in Relation to the Clinical Course of ATL: Frequent Clonal Change at Crisis From Indolent Disease Blood, February 1, 1997; 89(3): 948 - 956. [Abstract] [Full Text] [PDF]

				J. Lieberman and R. J. Buchsbaum Using T Cells to Treat B-Cell Cancers N. Engl. J. Med., April 28, 1994; 330(17): 1231 - 1233. [Full Text]

				G. Ficarra and L.E. Eversole HIV-Related Tumors of the Oral Cavity Critical Reviews in Oral Biology & Medicine, January 1, 1994; 5(2): 159 - 185. [Abstract] [Full Text] [PDF]

				G. Y. Lim, B. Newman, G. Kurland, and S. A. Webber Posttransplantation Lymphoproliferative Disorder: Manifestations in Pediatric Thoracic Organ Recipients Radiology, March 1, 2002; 222(3): 699 - 708. [Abstract] [Full Text] [PDF]